The ability to efficiently separate individual cells is essential in the development of biopharmaceuticals
Spotted: Biotech company Cytena has developed a single-cell printer that can isolate individual cells and dispense them one at a time. The ability to analyse single cells is essential in the development of biopharmaceuticals, and in cancer and stem cell research.
The German startup describes its technology as based on an “inkjet-like principle.” Cell samples are loaded into a dispensing cartridge. Small samples are displaced into a nozzle where an image is taken of each sample. A super-fast image processing algorithm counts the cells in each image and classifies them according to criteria such as size and shape. Tiny droplets are then ejected from the nozzle onto a storage plate, and any droplet containing more than one cell is redirected into a waste container.
Cytena recently raised £3 million in a Series A funding round. The new capital will be used to further develop the single-cell printing technology and to expand sales.